CBER Adcomm Skeptical of Allergen Immunotherapy Clinical Trials

Drug Industry Daily
A A
CBER’s Allergenic Products Advisory Committee gave a less than stellar assessment on the outlook of clinical trials for immunotherapies to treat food allergies.

To View This Article:

Login

Subscribe To Drug Industry Daily